Average Co-Inventor Count = 2.26
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of British Columbia (12 from 932 patents)
2. Promis Neurosciences Inc. (3 from 8 patents)
12 patents:
1. 12404321 - Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereof
2. 12286469 - Humanized antibodies binding to amyloid-beta (A-beta)
3. 12173055 - N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
4. 12071472 - Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
5. 11970522 - Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
6. 11905318 - Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
7. 11756650 - Systems and methods for predicting misfolded protein epitopes by collective coordinate biasing
8. 11214613 - Epitopes in the RNA recognition motif 1 (RRM1) of TDP-43 and misfolding-selective antibodies thereto
9. 10774120 - Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
10. 10772969 - N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
11. 10759837 - Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
12. 10475525 - Methods and systems for predicting misfolded protein epitopes